This inventor holds 1 USPTO granted patent. Top assignee: Texas A&M University System. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Christian E Oker-Blom: Innovator in Baculovirus Technology
Introduction
Christian E Oker-Blom is a notable inventor based in Turku, Finland. He has made significant contributions to the field of genetic engineering, particularly in the development of recombinant baculoviruses. His work focuses on creating innovative solutions for producing desired proteins and vaccines.
Latest Patents
Oker-Blom holds a patent for a "Baculovirus dual promoter expression vector." This invention involves the design and genetic engineering of recombinant baculoviruses to produce specific proteins, virus hybrids, or protein hybrids in compatible insect systems. The patent outlines the use of different baculovirus promoters to construct a recombinant baculovirus tailored to specific research needs. Notably, this technology can be utilized to produce viral pesticides and genetically engineered viruses that mimic authentic pathogens without the ability to replicate. The engineered baculovirus is designed for temporal regulation, allowing for the controlled synthesis of non-structural and structural proteins. This innovation has significant implications for the safe and cost-effective production of vaccines and diagnostics.
Career Highlights
Christian E Oker-Blom is affiliated with the University of Texas System, where he continues to advance his research in genetic engineering and virology. His work has garnered attention for its potential applications in medicine and agriculture.
Collaborations
Oker-Blom collaborates with Max D Summers, who is also involved in research related to baculovirus technology. Their partnership enhances the development of innovative solutions in the field.
Conclusion
Christian E Oker-Blom's contributions to baculovirus technology exemplify the intersection of innovation and practical application in genetic engineering. His work not only advances scientific understanding but also holds promise for future developments in vaccine production and disease management.